Literature DB >> 8877313

Optimal management of anxiety in older patients.

K J Weiss1.   

Abstract

Although the incidence of anxiety disorders diminishes with age, the prevalence of anxiety symptoms among older patients is substantial. These symptoms, which include cognitive and somatic manifestations, are a source of diminished quality of life. The many potential sources of illness- and medication-induced anxiety must be excluded before instituting treatment. The general principles of antianxiety medication treatment in older patients include: (i) symptom relief with minimum sedation; (ii) improvement in sleep; (iii) freedom from autonomic and cognitive toxicities; and (iv) freedom from physical dependence and drug interactions. Older compounds such as the tricyclic antidepressants should be avoided, since more modern agents (e.g. benzodiazepines and buspirone) are well tolerated and effective. Modern antidepressants have also been used to reduce anxiety symptoms, although there is a potential for the opposite effect to occur. The selective serotonin reuptake inhibitors appear to be better suited to treating syndromes such as panic and obsessive-compulsive disorder, whereas nefazodone would be a better choice for generalised anxiety complicated by depression.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8877313     DOI: 10.2165/00002512-199609030-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  66 in total

Review 1.  Practical considerations in the pharmacologic treatment of depression and anxiety in the elderly.

Authors:  C Salzman
Journal:  J Clin Psychiatry       Date:  1990-01       Impact factor: 4.384

Review 2.  5-HT receptors as targets for the development of novel anxiolytic drugs: models, mechanisms and future directions.

Authors:  J E Barrett; K E Vanover
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects.

Authors:  J C Ware; F V Rose; R H McBrayer
Journal:  Sleep       Date:  1994-09       Impact factor: 5.849

Review 4.  Diagnostic considerations and treatment approaches to underlying anxiety in the medically ill.

Authors:  M G Wise; S O Rieck
Journal:  J Clin Psychiatry       Date:  1993-05       Impact factor: 4.384

5.  Medication compliance in elderly outpatients using twice-daily dosing and unit-of-use packaging.

Authors:  M D Murray; J A Birt; A K Manatunga; J C Darnell
Journal:  Ann Pharmacother       Date:  1993-05       Impact factor: 3.154

6.  Anxiety disorders and marital quality.

Authors:  J D McLeod
Journal:  J Abnorm Psychol       Date:  1994-11

Review 7.  Medication compliance in the elderly.

Authors:  C Salzman
Journal:  J Clin Psychiatry       Date:  1995       Impact factor: 4.384

8.  The social costs of anxiety disorders.

Authors:  A C Leon; L Portera; M M Weissman
Journal:  Br J Psychiatry Suppl       Date:  1995-04

Review 9.  The role of serotonin in depression and anxiety.

Authors:  D Baldwin; S Rudge
Journal:  Int Clin Psychopharmacol       Date:  1995-01       Impact factor: 1.659

10.  Anxiety in elderly hearing impaired persons.

Authors:  G Andersson; M Green
Journal:  Percept Mot Skills       Date:  1995-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.